ACELYRIN, INC. Common StockSLRN

Capital at risk.

About ACELYRIN, INC. Common Stock
Ticker
info
SLRN
Trading on
info
NASDAQ
ISIN
info
US00445A1007
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Mina Kim J.D.
Headquarters
info
4149 Liberty Canyon Road, Agoura Hills, CA, United States, 91301
Employees
info
83
Website
info
acelyrin.com
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is lonigutamab, a subcutaneously delivered monoclonal antibody targeting IGF-1R for the treatment of Thyroid Eye Disease (TED), which is in Phase 2. Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California.
Metrics
BasicAdvanced
Market cap
info
$266M
P/E ratio
info
-
EPS
info
-$2.50
Dividend Yield
info
0.00%
Beta
info
-
Forward P/E ratio
info
0
EBIDTA
info
$-293M
Ex dividend date
info
-
Price & volume
Market cap
info
$266M
Average daily volume
info
1.3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
0.58
Earnings
EPS
info
-$2.50
EPS estimate (current quarter)
info
-$0.67
EPS estimate (next quarter)
info
-$0.95
EBITDA
info
$-293M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-
52-week High
info
$7.25
52-week Low
info
$1.85
50-day moving average
info
$2.31
200-day moving average
info
$4.20
Short ratio
info
1.27
Short %
info
4.89%
Management effectiveness
ROE (TTM)
info
44.54%
ROA (TTM)
info
29.73%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
101M
Float
info
72.4M
Insiders %
info
8.82%
Institutions %
info
105.69%
Analyst Insights & forecasts
info

58% Buy

42% Hold

0% Sell

Based on information from 7 analysts.

Average price target

info
$8.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.36
-$0.98
63.27%
Q1 • 24Beat
-$0.86
-$0.66
29.65%
Q2 • 24Beat
-$0.49
-$0.80
38.75%
Q3 • 24Beat
-$0.79
-$0.67
17.91%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-48.5M
∞%
Q3 • 24
$0M
$-79M
∞%
Q4 • 24
NaN%
62.79%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$618M
$90M
14.56%
Q3 • 24
$491M
$32.8M
6.69%
Q4 • 24
20.57%
63.51%
54.07%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-78.8M
$166M
$1M
$-79.1M
Q3 • 24
$-122M
$-22.7M
$1.9M
$-122M
Q4 • 24
54.36%
113.70%
85.79%
53.89%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a ACELYRIN, INC. Common Stock share?
Collapse

ACELYRIN, INC. Common Stock shares are currently traded for undefined per share.

How many shares does ACELYRIN, INC. Common Stock have?
Collapse

ACELYRIN, INC. Common Stock currently has 101M shares.

Does ACELYRIN, INC. Common Stock pay dividends?
Collapse

No, ACELYRIN, INC. Common Stock doesn't pay dividends.

What is ACELYRIN, INC. Common Stock 52 week high?
Collapse

ACELYRIN, INC. Common Stock 52 week high is $7.25.

What is ACELYRIN, INC. Common Stock 52 week low?
Collapse

ACELYRIN, INC. Common Stock 52 week low is $1.85.

What is the 200-day moving average of ACELYRIN, INC. Common Stock?
Collapse

ACELYRIN, INC. Common Stock 200-day moving average is $4.20.

Who is ACELYRIN, INC. Common Stock CEO?
Collapse

The CEO of ACELYRIN, INC. Common Stock is Mina Kim J.D..

How many employees ACELYRIN, INC. Common Stock has?
Collapse

ACELYRIN, INC. Common Stock has 83 employees.

What is the market cap of ACELYRIN, INC. Common Stock?
Collapse

The market cap of ACELYRIN, INC. Common Stock is $266M.

What is the P/E of ACELYRIN, INC. Common Stock?
Collapse

The current P/E of ACELYRIN, INC. Common Stock is null.

What is the EPS of ACELYRIN, INC. Common Stock?
Collapse

The EPS of ACELYRIN, INC. Common Stock is -$2.50.

What is the PEG Ratio of ACELYRIN, INC. Common Stock?
Collapse

The PEG Ratio of ACELYRIN, INC. Common Stock is null.

What do analysts say about ACELYRIN, INC. Common Stock?
Collapse

According to the analysts ACELYRIN, INC. Common Stock is considered a buy.